Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat vs allopurinol in gout-related hyperuricemia
CTR20130132Phase 3Completed
- Sponsor
- China Resources Saike Pharmaceutical
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of febuxostat in gout, hyperuricemia, sponsored by China Resources Saike Pharmaceutical. Started Jul 2014; status: completed.
02
Drugs
febuxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on CTR20130132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130132.